BRIEF published on 10/30/2025 at 17:50, 1 year ago AXA Reports 7% Revenue Growth in 2025’s First Nine Months Revenue Growth Solvency Ratio Property & Casualty Life & Health AXA Strategy
REGULATED PRESS RELEASE published on 10/30/2025 at 17:45, 1 year ago AXA: 9M25 Activity Indicators AXA reports 7% revenue growth in first nine months of 2025. Property & Casualty premiums up 5% to Euro 46.2 billion. Life & Health premiums up 9% to Euro 42.3 billion. Solvency II ratio at 222% Revenue Growth AXA Solvency II Ratio Property & Casualty Life & Health
REGULATED PRESS RELEASE published on 10/30/2025 at 17:45, 1 year ago AXA : Indicateurs d'activité du 9M 2025
BRIEF published on 10/10/2025 at 18:05, 1 year ago AXA Reports Share Capital and Voting Rights as of September 2025 Share Capital Voting Rights French Commercial Code AXA Disclosure
BRIEF published on 10/10/2025 at 18:05, 1 year ago AXA : Bilan des Actions et Droits de Vote au 30 septembre 2025 Droits De Vote Capital Social Paris AXA Déclaration De Seuils
REGULATED PRESS RELEASE published on 10/10/2025 at 18:00, 1 year ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/09/2025 AXA annonce le nombre total d'actions et de droits de vote composant son capital social selon les obligations réglementaires en vigueur Euronext Paris Droits De Vote Capital Social AXA Obligations Réglementaires
REGULATED PRESS RELEASE published on 10/10/2025 at 18:00, 1 year ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2025 AXA, a public company under French law, discloses information on voting rights and share capital. Details conform to French Commercial Code and AMF regulations Share Capital Voting Rights AXA AMF Regulations French Law
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:30, 39 minutes ago Hannover Re increases Group profit and confirms full-year guidance
Published on 11/09/2026 at 07:30, 39 minutes ago SUSS Expands Photomask Portfolio with Next-Generation ASC9500 Mid-End Cleaner
Published on 11/09/2026 at 07:30, 39 minutes ago GEA delivers strong third quarter: order intake rises substantially, revenue and profitability further improved
Published on 11/09/2026 at 07:30, 39 minutes ago Nordex Group to enter Albania with 84 MW order from Verbund
Published on 11/09/2026 at 07:30, 39 minutes ago q.beyond posts high volume of one-off charges in Q3 2026 – restructuring set to pay off from 2027 onwards
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 9 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026